| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0009-9120(03)00110-3 |
| P698 | PubMed publication ID | 14636880 |
| P50 | author | Robert A. Hegele | Q58046422 |
| P2093 | author name string | Jian Wang | |
| Tisha Joy | |||
| Angelika Hahn | |||
| P2860 | cites work | Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis | Q24564368 |
| Variant apolipoprotein AI as a major constituent of a human hereditary amyloid | Q28610075 | ||
| Livers from patients with apolipoprotein A-I amyloidosis are not suitable as "domino" donors | Q34282675 | ||
| Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis | Q35745590 | ||
| Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. | Q35754591 | ||
| Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene | Q37356259 | ||
| The systemic amyloidoses | Q41596634 | ||
| The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide | Q42795318 | ||
| Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer | Q44642406 | ||
| A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis | Q47972740 | ||
| Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis | Q55670644 | ||
| A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy | Q68367680 | ||
| Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg | Q73875344 | ||
| Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I | Q74165052 | ||
| P433 | issue | 8 | |
| P921 | main subject | literature review | Q2412849 |
| P304 | page(s) | 641-645 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Clinical Biochemistry | Q5133749 |
| P1476 | title | APOA1 related amyloidosis: a case report and literature review | |
| P478 | volume | 36 |
| Q41428960 | 18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis |
| Q34544856 | A Novel Mutation in ABCA1 Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological Presentation |
| Q58283280 | AApoAIL75P amyloidosis causes cirrhosis-like appearance of the liver in the absence of laboratory or clinical signs of hepatic dysfunction |
| Q35978258 | Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes |
| Q89860842 | Amyloidogenic Peptides in Human Neuro-Degenerative Diseases and in Microorganisms: A Sorrow Shared Is a Sorrow Halved? |
| Q31029305 | Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. |
| Q36383801 | An uncommon cause of bifacial weakness and non-length-dependent demyelinating neuropathy |
| Q90613707 | Apolipoprotein A1 in Cerebrospinal Fluid Is Insufficient to Distinguish Alzheimer's Disease from Other Dementias in a Naturalistic, Clinical Setting |
| Q64360743 | Apolipoprotein CII Amyloidosis Associated With p.Lys41Thr Mutation |
| Q83013556 | Clinical and electrophysiological characteristics of neuropathy associated with Tangier disease |
| Q55243030 | Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I. |
| Q43150693 | Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation |
| Q46154671 | Electron paramagnetic resonance spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apoA-I in solution |
| Q59150078 | FRET evidence for untwisting of amyloid fibrils on the surface of model membranes |
| Q38099536 | Genetics of HDL-C: a causal link to atherosclerosis? |
| Q38543423 | Interactions of Lipid Membranes with Fibrillar Protein Aggregates |
| Q36833883 | Mapping the structural transition in an amyloidogenic apolipoprotein A-I |
| Q34440462 | Mass spectrometry analysis reveals non-mutated apolipoprotein A1 lumbosacral radiculoplexus amyloidoma. |
| Q34570581 | Maternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13. |
| Q34013516 | Medullary amyloidosis associated with apolipoprotein A-IV deposition |
| Q46850433 | Pathology and diagnosis of renal non-AL amyloidosis. |
| Q36662860 | Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy |
| Q41046690 | Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox? |
Search more.